EarningsQ3 2024 Earnings Report

COSCIENS Biopharma (ET80) Q3 2024 Earnings Report

0 Followers

DE:ET80 Q3 2024 EPS Results

Actual EPS-€4.78

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€8.78

Actual Revenue€1.59M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+63322.78%

QuarterQ3 2024

Date11/12/2024

TimeBefore Open

Conference CallTuesday, November 12, 2024

DE:ET80 Upcoming Earnings

COSCIENS Biopharma's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	- / -	-1.472	―
Aug 11, 2026	2026 (Q2)	- / -0.17	-2.199	92.44% (+2.03)
May 12, 2026	2026 (Q1)	- / -0.44	-3.114	85.97% (+2.68)
Apr 15, 2026	2025 (Q4)	- / -1.79	-5.606	68.15% (+3.82)
Nov 11, 2025	2025 (Q3)	- / -1.47	-3.454	57.39% (+1.98)
Aug 14, 2025	2025 (Q2)	- / -2.20	-1.195	-84.06% (-1.00)
May 13, 2025	2025 (Q1)	- / -1.00	-12.246	91.84% (+11.25)
Apr 09, 2025	2024 (Q4)	- / -3.11	-8.85	64.82% (+5.74)
Nov 12, 2024	2024 (Q3)	- / -4.78	-8.784	45.59% (+4.00)
Aug 08, 2024	2024 (Q2)	- / -	-0.324	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed